National Health (Pharmaceutical Benefits) Regulations (Amendment) (Cth)

STATUTORY RULES

1967 No.

_________

REGULATIONS UNDER THE NATIONAL HEALTH ACT 1953-1967.*

I, THE ADMINISTRATOR of the Government of the Commonwealth of Australia, acting with the advice of the Federal Executive Council, hereby make the following Regulations under the National Health Act 1953-1967.

Dated this twenty-sixth day of May, 1967.

EDRIC BASTYAN

Administrator.

By His Excellency’s Command,

(Signed) A. G. Forbes

Minister of State for Health.

_________

Amendments of the National Health (Pharmaceutical Benefits) regulations 

Commencement.

1.These Regulations shall come into operation on the first day of June, 1967.

First, Second, Third, Fourth and Fifth Schedules.

2. The First, Second, Third, Fourth and Fifth Schedules to the National Health (Pharmaceutical Benefits) Regulations arc repealed and the following Schedules inserted in their stead:—

FIRST SCHEDULE

Regulation 10.

Drugs and Medicinal Preparations in the British Pharmacopoeia that are not to be supplied as, or except as specially provided used in, pharmaceutical benefits

Acetomenaphthone.	Benztropine Methanesulphonate.
Acetomenaphthone Tablets.	Betamethasone.
Acetrizoic Acid.	Betamethasone Sodium Phosphate Tablets.
Alcohol (95%).	Bisacodyl.
Alcohol Dehydrated.	Bisacodyl Suppositories.
Alcohols Dilute.	Bisacodyl Tablets.
Almond Oil.	Busulphan.
Amethocaine Hydrochloride.	Butobarbitone.
Amitriptyline Hydrochloride.	Butylated Hydroxyanisole.
Amitriptyline Injection.	Butylated Hydroxytoluene.
Amodiaquine Hydrochloride.	Calciferol Solution.
Amphetamine Sulphate.	Calcium Cyclamate.
Amylobarbitone Sodium Tablets.	Caramiphen Hydrochloride.
Anaesthetic Ether.	Caramiphen Tablets.
Antazoline Hydrochloride.	Caraway.
Antimony Potassium Tartrate.	Carbimazole.
Antimony Potassium Tartrate Injection.	Carbon Dioxide.
Antimony Sodium Tartrate.	Carbromal Tablets.
Antimony Sodium Tartrate Injection.	Cardamom Fruit.
Apomorphine Hydrochloride.	Cascara.
Apomorphine Injection.	Catgut, Sterilised Surgical.
Bacillus Calmette-Guérin Vaccine.	Cellulose, Oxidised.
Bemegride.	Cetylpyridinium Chloride.
Benzhexol Hydrochloride.	Chloral Betaine.

 

* Notified in the Commonwealth Gazette on                                                              1967.

  Statutory Rules 1960, No. 17, as amended by Statutory Rules 1960, Nos. 90 and 102; 1961, Nos. 59 and 137, 1962, Nos. 34, 101 and 114; 1963, Nos. 34, 69 and 107; 1964, Nos. 12, 57 and 135; 1965, Nos. 51, 151 and 152; and 1966, Nos. 80 and 144.

4281/67—Price 25c 10/18.5.1967

First Schedule—continued

Chlorambucil.	Diodone Injection.
Chlordiazepoxide Capsules.	Diphtheria and Pertussis Vaccine.
Chlordiazepoxide Hydrochloride.	Diphtheria, Tetanus and Poliomyelitis Vaccine.
Chloroquine Phosphate.	Dipipanone Hydrochloride.
Chloroquine Phosphate Injection.	Dipipanone Injection.
Chloroquine Sulphate.	Dodecyl Gallate.
Chlorothiazide.	Domiphen Bromide.
Chlorphenesin.	Edrophonium Chloride.
Chlorproguanil Hydrochloride.	Emetine and Bismuth Iodide.
Chlorproguanil Tablets.	Emetine Hydrochloride.
Chlorpropamide.	Erythromycin.
Choline Theophyllinate.	Ethinyloestradiol.
Choline Theophyllinate Tablets.	Ethisterone.
Chorionic Gonadotrophin.	Ethopropazine Hydrochloride.
Chorionic Gonadotrophin Injection.	Ethotoin.
Cinchocaine Hydrochloride.	Ethyl Chloride.
Cinnamon.	Ethyl Oleate.
Citric Acid, Anhydrous.	Ethylenediamine Hydrate.
Cochineal.	Eugenol.
Codeine Compound Tablets.	Ferric Citrate (50Fe) Injection.
Codeine Compound Soluble Tablets.	Fludrocortisone Acetate.
Colchicine.	Fluocinolone Acetonide.
Colchicum Corm.	Fluoxymesterone.
Colchicum Liquid Extract.	Gallamine Triethiodide.
Colistin Sulphate.	Gallamine Injection.
Colistin Tablets.	Gelatin Sponge, Absorbable.
Coriander.	Gentian.
Corticotrophin.	Ginger.
Cresol and Soap Solution.	Gold (108 Au) Injection.
Cresol.	Griseofulvin.
Crotamiton.	Halothane.
Cyanocabalamin.	Helium.
Cyanocobalamin (57 Co).	Heparin.
Cyanocobalamin (58 Co).	Hexamethonium Tartrate.
Cyclamic Acid.	Hexamethonium Tartrate Injection.
Cyclizine Tablets.	Hexylresorcinol.
Cyclobarbitone Calcium.	Histamine Acid Phosphate.
Cyclomethycaine Sulphate.	Histamine Acid Phosphate Injection.
Cyclopropane.	Human Blood, Whole.
Dapsone.	Human Red Blood, Corpuscles, Concentrated.
Deoxycortone Trimethylacetate.	Human Fibrin Foam.
Dequalinium Acetate.	Human Fibrinogen.
Dequalinium Chloride.	Human Gamma Globulin.
Dexamethasone.	Human Gamma Globulin Injection.
Dexamethasone Acetate.	Human Plasma, Dried.
Dexamphetamine Sulphate.	Human Serum, Dried.
Dextran 110 Injection.	Human Thrombin.
Dextromethorphan Hydrobromide.	Hydrallazine Hydrochloride.
Dextromethorphan Tablets.	Hydrallazine Tablets.
Dextropropoxyphene Capsules.	Hydrocortisone Ointment.
Dextropropoxyphene Hydrochloride.	Hydrocortisone Acetate Ointment.
Diamorphine Hydrochloride.	Hydrocortisone Hydrogen Succinate.
Diamorphine Injection.	Hydrocortisone Sodium Succinate.
Dibromopropamidine Isethionate.	Hydroflumethiazide.
Dichloralphenazone.	Hydrogen Peroxide Solution, Strong.
Dichlorophen.	Hydroxocobalamin.
Dichlorphenamide.	Hydroxychloroquine Sulphate.
Diethazine Hydrochloride.	Hyoscine Injection.
Diethylcarbamazine Citrate.	Hyoscine Hydrobromide.
Digitoxin.	Hyoscyamus.
Diloxanide Furoate.	Imipramine Hydrochloride.
Dimenhydrinate.	Indigo Carmine.
Dimenhydrinate Injection.	Influenza Vaccine.
Dimenhydrinate Tablets.	Iodinated (131I) Human Serum Albumin Injection.
Dimercaprol.	Iodipamide Methylglucamine Injection.
Dimethisterone.	Iodised Oil Fluid Injection.
Dimethisterone Tablets.	Iodised Oil Viscous Injection.

 

First Schedule—continued

Iopanoic Acid.	Novobiocin Sodium.
Iopanoic Acid Tablets.	Nux Vomica.
Iophendylate Injection.	Octyl Gallate.
Iothalmic Acid.	Oestradiol Benzoate.
Ipecacuanha, Prepared.	Opium.
Ipecacuanha and Opium Tablets.	Opium, Powdered.
Isoniazid.	Orange Peel, Dried Bitter.
Isopropyl Alcohol.	Orange Peel, Fresh Bitter.
Lead Acetate.	Oxygen.
Lead Monoxide.	Oxyphencyclamine Hydrochloride.
Lemon Peel, Dried.	Oxytetracycline Dihydrate.
Levallorphan Injection.	Paramethadione.
Levorphanol Tartrate.	Paromomycin Capsules.
Lignocaine Hydrochloride.	Paromomycin Sulphate.
Lignocaine and Adrenaline Injection.	Pempidine Tartrate.
Lignocaine Hydrochloride Injection.	Pentamidine Isethionate.
Liothyronine Sodium.	Pentamidine Injection.
Lucanthone Hydrochloride.	Pentolinium Tartrate Tablets.
Lucanthone Tablets.	Perphenazine.
Magnesium Stearate.	Perphenazine Tablets.
Maize Oil.	Pethidine Tablets.
Male Fern.	Phanquone.
Maleic Acid.	Phanquone Tablets.
Measles Vaccine (Inactivated).	Phenacetin.
Measles Vaccine (Live Attenuated).	Phenelzine Sulphate.
Mecamylamine Hydrochloride.	Phenelzine Tablets.
Meglumine Iothalamate Injection.	Phenglutarimide Hydrochloride.
Melarsoprol.	Phenglutarimide Tablets.
Menaphthone.	Phenindamine Tartrate.
Menaphthone Sodium Bisulphite Injection.	Phenindione.
Menaphthone Sodium Bisulphite.	Phenmetrazine Hydrochloride.
Mepacrine Hydrochloride.	Phenmetrazine Tablets.
Mephentermine Sulphate.	Phenolphthalein Tablets.
Mephentermine Tablets.	Phenolsulphonphthalein.
Meprobamate.	Phenoxybenzamine Hydrochloride.
Meprobamate Tablets.	Phenoxymethylpenicillin.
Mercaptopurine.	Phentolamine Hydrochloride.
Mersalyl Acid.	Phentolamine Tablets.
Metaraminol Tartrate.	Phentolamine Methanesulphonate.
Methadone Hydrochloride.	Phentolamine Injection.
Methandienone.	Phytomenadione.
Methohexitone Injection.	Phytomenadione Capsules.
Methoin.	Phytomenadione Tablets.
Methyl Hydroxybenzoate.	Picrotoxin.
Methylamphetamine Hydrochloride.	Picrotoxin Injection.
Methyldopa.	Piperazine Citrate.
Methylergometrine Maleate.	Piperocaine Hydrochloride.
Methylthiouracil.	Poldine Methylsulphate.
Methylthiouracil Tablets.	Poldine Tablets.
Methyprylone.	Poliomyelitis Vaccine (Inactivated).
Methyprylone Tablets.	Poliomyelitis Vaccine (Oral).
Metronidazole.	Potassium Chloride Injection.
Nalorphine Hydrobromide.	Potassium Perchlorate.
Nandrolone Phenylpropionate.	Prednisolone Sodium Phosphate Injection
Naphazoline Hydrochloride.	Prednisone.
Neostigmine Bromide.	Prednisone Acetate.
Nialamide.	Primaquine Phosphate.
Nialamide Tablets.	Probenecid.
Nicotinic Acid.	Procaine and Adrenaline Injection.
Nikethamide.	Prochlorperazine Maleate.
Nikethamide Injection.	Prochlorperazine Methanesulphonate.
Nitrous Oxide.	Prochlorperazine Tablets.
Norethandrolone.	Procyclidine Hydrochloride.
Norethandrolone Tablets.	Progesterone.
Norethisterone.	Proguanil Hydrochloride.
Norethisterone Tablets.	Promazine Hydrochloride.
Noscapine.	Promazine Injection.
Novobiocin Calcium.	Promazine Tablets.

First Schedule—continued

Promethazine Theoclate.	Sulphamethoxydiazine.
Phomethazine Theoclate Tablets.	Sulphamethoxypyridazine.
Pronethalol Hydrochloride.	Sulphapyridine.
Pronethalol Injection.	Sulphasomidine.
Phonethalol Tablets.	Sulphasomidine Tablets.
Propyl Gallate.	Sulphinpyrazone.
Propyl Hydroxybenzoate.	Sulphobromophthalein Sodium.
Propyliodone.	Suramin.
Propyliodone Injection.	Suramin Injection.
Propyliodone Oily Injection.	Suxamethonium Chloride.
Propylthiouracil.	Testosterone.
Pyridostigmine Bromide.	Testosterone Phenylpropionate.
Pyrimethamine.	Testosterone Phenylpropionate Injection.
Pyrimethamine Tablets.	Testosterone Propionate.
Quillaia.	Tetanus and Pertussis Vaccine.
Rabies Antiserum.	Tetanus Vaccine (Alum Precipitated).
Rabies Vaccine.	Tetanus Vaccine (Purified Toxoid Aluminimum Hydroxide).
Santonin.	Tetanus Vaccine (Simple Solution).
Senna Leaf.	Tetrachloroethylene.
Sesame Oil.	Tetrachloroethylene Capsules.
Soda Lime.	Thiambutosine.
Sodium Acetriozoate Injection.	Thiomersal.
Sodium Anoxynaphthonate.	Thiopentone Sodium.
Sodium Antimonylgluconate.	Thiopentone Injection.
Sodium Antimonylgluconate Injection.	Thioridazine Hydrochloride.
Sodium Aurothiomalate.	Thyroid.
Sodium Bicarbonate Compound Tablets.	Thyroxine Sodium.
Sodium Bicarbonate Injection.	Tolazoline Hydrochloride.
Sodium Calciumedetate.	Tolbutamide.
Sodium Chromate (51Cr) Solution.	Tranylcypromine Sulphate.
Sodium Citrate Tablets.	Tranylcypromine Tablets.
Sodium Cyclamate.	Trichloroethylene.
Sodium Diatrizoate.	Triclofos Sodium.
Sodium Diatrizoate Injection.	Triclofos Tablets.
Sodium Fluoride.	Tricyclamol Chloride.
Sodium Fusidate Capsules.	Tripelennamine Hydrochloride.
Sodium Iodide (181I) Injection.	Tryparsamide.
Sodium Iodide (101I) Solution.	Tryparsamide Injection.
Sodium Iothalamate Injection.	Tuberculin, Old.
Sodium Lauryl Sulphate.	Tuberculin Purified Protein Derivative.
Sodium Phosphate (32P) Injection.	Tubocurarine Chloride.
Sodium Stibogluconate.	Tubocurarine Injection.
Sodium Stibogluconate Injection.	Typhoid-Paratyphoid A and B and Cholera Vaccine.
Solapsone.	Typhoid-Paratyphoid A and B and Tetanus Vaccine.
Solapsone Tablets.	Typhoid-Paratyphoid A, B, and C Vaccine
Spironolactone.	Undecenoic Acid.
Staphylococcus Antitoxin.	Vancomycin Hydrochloride.
Stibophen.	Vancomycin Injection.
Stibophen Injection.	Vinyl Ether.
Stramonium.	Vitamin A Ester Concentrate.
Sulphadimethoxine.	Yellow Fever Vaccine.
Sulphadimidine Sodium.	Zinc Undecenoate.
Sulphamethizole.	Zinc Undecenoate Ointment.

__________________________

SECOND SCHEDULE

Regulation 10 (3.).

Allowable Compounds (if any) of Certain Drugs or Medicinal Preparations

Pharmaceutical Benefits	Allowable Compounds (if any)
Acetylcysteine........................................................................................	—
Acrylic Resin..........................................................................................	—
Aluminium Powder, B.P.C..................................................................	Aluminium Powder B.P.C. with Liquid Paraffin B.P. and Zinc Oxide Ointment B.P.
Amino Acids...........................................................................................	Amino Acids with Sorbitol
Amino Acids with Sorbitol and Ethanol
Amphotericin B.....................................................................................	Tetracycline with a buffering agent and Amphotericin B.
Aneurine Hydrochloride, B.P..............................................................	Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D
Antazoline Sulphate.............................................................................	Antazoline Sulphate with Naphazoline Nitrate B.P.
Ascorbic Acid, B.P................................................................................	Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D
Attapulgite..............................................................................................	Dihydrostreptomycin Sulphate B.P. 1958 with Attapulgite, Pectin and Hydrated Alumina Powder B.P.
Bacitracin, B.P.......................................................................................	Polymyxin B Sulphate B.P. with Bacitracin B.P. and Neomycin Sulphate B.P.
Betamethasone Sodium Phosphate, B.P...........................................	—
Betamethasone Phosphate..................................................................	—
Brompheniramine Maleate.................................................................	—
Calciferol................................................................................................	—
Carbachol, B.P.......................................................................................	—
Carbinoxamine Maleate......................................................................	—
Carbromal, B.P......................................................................................	Carbromal B.P., with Pentobarbitone Sodium B.P.
Chloramine, B.P.C................................................................................	—
Chloramphenicol, B.P...........................................................................	Chloramphenicol B.P. with Polymyxin B. Sulphate B.P.
Chlorhexidine Gluconate.....................................................................	—
Chlorpheniramine Maleate, B.P.........................................................	—
Chlorpromazine Hydrochloride, B.P.................................................	—
Chlortetracycline Hydrochloride, B.P...............................................	—
Clemizole Tannate...............................................................................	—
Cortisone Acetate, B.P.........................................................................	—
Cymogran...............................................................................................	—
Cyproheptadine Hydrochloride B.P...................................................	—
Cyclizine Hydrochloride, B.P.............................................................	Ergotamine Tartrate B.P. with Caffeine B.P. and Cyclizine Hydrochloride B.P.
Demecarium Bromide..........................................................................	—
Demethylchlortetracycline Hydrochloride, B.P...............................	Demethylchlortetracycline Hydrochloride B.P. with Nystatin B.P.
Dexchlorpheniramine Maleate...........................................................	—
Dextran...................................................................................................	Dextran with Dextrose B.P.
Dextran in Normal Saline
Dicyclomine Hydrochloride, B.P.......................................................	—
Dienoestrol, B.P.....................................................................................	—
Digoxin, B.P...........................................................................................	—
Dihydrostreptomycin Sulphate, B.P. 1958.......................................	Dihydrostreptomycin Sulphate B.P. 1958 with Attapulgite, Pectin and Hydrated Alumina Powder B.P.
Dihydrostreptomycin Sulphate B.P. 1958 with Kaolin, Pectin and Aluminium Hydroxide Gel
Dihydrotachysterol...............................................................................	—
Dimethicone...........................................................................................	—
Diphenhydramine Hydrochloride, B.P..............................................	Ergotamine Tartrate B.P. with Caffeine Citrate B.P.C. 1959 and Diphenhydramine Hydrochloride B.P.
Diphenylpyraline Hydrochloride........................................................	—
Diphtheria Vaccine, B.P.......................................................................	Diphtheria Tetanus Vaccine B.P. Purified Toxoid (Aluminium Phosphate Adsorbed) B.P.
Diphtheria Tetanus Purified Toxoid (Aluminium Phosphate Adsorbed) and Pertussis Vaccine B.P.

Second Schedule—continued

Pharmaceutical Benefits	Allowable Compounds (if any)
Dyflos, B.P.C.........................................................................................	—
Ecothiopate Iodide................................................................................	—
Entsufon.................................................................................................	Hexachlorophane B.P. with Entsufon
Ergometrine Maleate............................................................................	Oxytocin with Ergometrine Maleate
Ergotamine Tartrate, B.P.....................................................................	Ergotamine Tartrate B.P. with Caffeine B.P.
Ergotamine Tartrate B.P. with Caffeine B.P. and Cyclizine Hydrochloride B.P.
Ergotamine Tartrate B.P. with Caffeine Citrate B.P.C. 1959 and Diphenhydramine Hydrochloride B.P.
Ergotamine Tartrate B.P. with Caffeine B.P. and Meclozine Hydrochloride B.P.
Erythromycin Oral Suspensions and Syrups....................................	—
Erythromycin Paediatric Drops...........................................................	—
Ethosuximide.........................................................................................	—
Ferric Hydroxide...................................................................................	—
Ferrous Aminoacetosulphate..............................................................	—
Ferrous Succinate..................................................................................	—
Framycetin Sulphate.............................................................................	—
Fusidic Acid (Diethanolamine Salt)...................................................	—
Galactomin, Formula No. 11..............................................................	—
Glucose Indicator..................................................................................	—
Glyceryl Guiaiacolate..........................................................................	Theophylline with Glyceryl Guaiacolate
Gramicidin..............................................................................................	Polymyxin B. Sulphate B.P. with Neomycin Sulphate B.P. and Gramicidin
Hexachlorophane, B.P..........................................................................	Hexachlorophane B.P. with Entsufon
Hexachlorophane B.P. with Lissapol
Hexachlorophane B.P. in Soap Solution
Hydrocortisone, B.P..............................................................................	—
Hydrocortisone Acetate, B.P...............................................................	Hydrocortisone Acetate B.P. with Neomycin Sulphate B.P.
Idoxuridine.............................................................................................	—
Ipecacuanha, B.P...................................................................................	Phenolphthalein B.P. with Aloin B.P.C., Dry Extract of Belladonna B.P., Strychnine B.P.C. 1959 and Ipecacuanha B.P.
Isoprenaline Hydrochloride.................................................................	—
Kanamycin Sulphate, B.P.C................................................................	—
Levallorphan Tartrate, B.P..................................................................	Levallorphan Tartrate B.P. with Pethidine Hydrochloride B.P.
Lissapol...................................................................................................	Lissapol with Spearmint Oil B.P.C. and Cetrimide B.P.
Hexachlorophane B.P. with Lissapol
Lofenalac...............................................................................................	—
Magnesium Chloride.............................................................................	Ammonium Chloride B.P. with Sodium Chloride B.P., Potassium Chloride B.P. and Magnesium Chloride

Sodium Lactate with Potassium Chloride B.P., Magnesium Chloride and Sodium Chloride B.P.
Mebhydrolin Napadisylate, B.P.C......................................................	—
Meclozine Hydrochloride, B.P............................................................	Ergotamine Tartrate B.P. with Caffeine B.P. and Meclozine Hydrochloride B.P.
Mepyramine Maleate, B.P...................................................................	—
Methacycline.........................................................................................	—
Methdilazine Hydrochloride...............................................................	—
Methenamine Mandelate.....................................................................	—
Methyl Glucamine................................................................................	Theophylline B.P. with Methyl Glucamine
Minafen..................................................................................................	—
Morphine Tartrate.................................................................................	Morphine Tartrate with Tacrine
Naphazoline Nitrate, B.P.....................................................................	Naphazoline Nitrate B.P. with Antazoline Sulphate
Neomycin Sulphate, B.P......................................................................	Hydrocortisone Acetate B.P. with Neomycin Sulphate B.P.
Polymyxin B. Sulphate B.P. with Bacitracin B.P. and Neomycin Sulphate B.P.
Neomycin Sulphate B.P. with Kaolin B.P.
Polymyxin B. Sulphate B.P. with Neomycin Sulphate B.P. and Gramicidin

Second Schedule—continued

Pharmaceutical Benefits	Allowable Compounds (if any)
Neostigmine Methylsulphate, B.P...............................................	—
Nicotinamide, B.P...........................................................................	Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D
Nitrofurantoin, B.P.........................................................................	—
Nortriptyline Hydrochloride, B.P................................................	—
Nystatin, B.P....................................................................................	Tetracycline with a buffering agent and Nystatin B.P.
Oxytetracycline Hydrochloride B.P. with a buffering agent and Nystatin B.P.
Demethylchlortetracycline Hydrochloride B.P. with Nystatin B.P.
Nutramigen......................................................................................	—
Oxytetracycline Hydrochloride, B.P...........................................	Oxytetracycline Hydrochloride B.P. with Polymyxin B. Sulphate B.P.
Oxytetracycline Hydrochloride B.P. with a buffering agent and Nystatin B.P.
Oxytocin...........................................................................................	Oxytocin with Ergometrine Maleate
Pancreatin Enzyme, U.S.N.F. XI.................................................	—
Papaveretum, B.P.C.......................................................................	Papaveretum B.P.C. with Hyoscine Hydrobromide B.P.
Penicillin, Benethamine, B.P.C....................................................	Penicillin, Benethamine B.P.C. with Procaine Penicillin B.P. and Sodium Penicillin B.P.
Penicillin, Benzathine, B.P...........................................................	Penicillin, Benzathine B.P. with Procaine Penicillin B.P. and Potassium Penicillin B.P.
Penicillin, Benzyl, B.P...................................................................	Penicillin, Benzyl B.P. with Streptomycin Sulphate B.P.
Fortified Procaine Penicillin Injection B.P.
Penicillin, Benzyl B.P. with Procaine Penicillin B.P. and Streptomycin Sulphate B.P.
Penicillin, Phenoxymethyl (Benzathine, Calcium,................... Hydrabamine or Potassium Salt or Free Acid)..........................	—
Penicillin, Potassium, B.P.............................................................	Penicillin, Benzathine B.P. with Procaine Penicillin B.P. and Potassium Penicillin B.P.
Penicillin, Procaine, B.P................................................................	Penicillin, Benzathine B.P. with Procaine Penicillin B.P. and Potassium Penicillin B.P.
Fortified Procaine Penicillin Injection B.P.
Penicillin, Benethamine B.P.C. with Procaine Penicillin B.P. and Sodium Penicillin B.P.
Penicillin, Benzyl B.P. with Procaine Penicillin B.P. and Streptomycin Sulphate B.P.
Penicillin, Sodium, B.P..................................................................	Penicillin, Benethamine B.P. with Procaine Penicillin B.P. and Sodium Penicillin B.P.
Pertussis Vaccine, B.P...................................................................	Diphtheria, Tetanus Purified Toxoid (Aluminium Phosphate Adsorbed) and Pertussis Vaccine B.P.
Pethidine Hydrochloride, B.P.......................................................	Pethidine Hydrochloride B.P. with Levallorphan Tartrate B.P.
Pethidine Hydrochloride B.P. with Scopolamine Hydrobromide B.P.
Phenethicillin Potassium, B.P.......................................................	—
Pheniramine Maleate.....................................................................	—
Phenytain.........................................................................................	—
Pilocarpine Hydrochloride............................................................	—
Pipenzolate Methobromide..........................................................	—
Pituitary (Posterior Lobe), Powdered, B.P.C.............................	—
Polymyxin B. Sulphate, B.P.........................................................	Chloramphenicol B.P. with Polymyxin B. Sulphate B.P.
Oxytetracycline Hydrochloride B.P. with Polymyxin B. Sulphate B.P.
Polymyxin B. Sulphate B.P. with Bacitracin B.P. and Neomycin Sulphate B.P.
Polymyxin B. Sulphate B.P. with Neomycin Sulphate B.P. and Gramicidin
Polymyxin B. Sulphate B.P. with Propylene Glycol and Acetic acid
Methylprednisolone, B.P...............................................................	—

Second Schedule—continued

Pharmaceutical Benefits	Allowable Compounds (if any)
Prednisolone Sodium Hemisulphate...................................	—
Prednisolone Sodium Phosphate, B.P..................................	—
Prednisolone Trimethylacetate, B.P.....................................	—
Primidone B.P..........................................................................	—
Promethazine Hydrochloride, B.P........................................	—
Riboflavine, B.P......................................................................	Vitamin A with Aneurine Hydrochloride B.P. Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D
Senna Fruit, B.P.......................................................................	—
Silver Nitrate, Toughened, B.P.............................................	—
Sobee.........................................................................................	—
Sodium Aminosalicylate B.P................................................	Sodium Aminosalicylate B.P. with Isoniazid B.P.
Sodium Lactate.......................................................................	Sodium Lactate with Potassium Chloride B.P. and Sodium Chloride B.P.
Sodium Lactate with Potassium Chloride B.P., Magnesium Chloride and Sodium Chloride B.P.
Sodium Lactate with Sodium Chloride B.P. and Dextrose B.P.
Sodium Lactate with Sodium Chloride B.P.
Sodium Lactate with Potassium Chloride B.P. and Dextrose B.P.
Sodium Potassium Tartrate, B.P.C.......................................	Compound Effervescent Powder B.P.C.
Sodium Tauroglycocholate, B.P.C. 1954...........................	Sodium Tauroglycocholate B.P.C. 1954 with Cascara Dry Extract B.P.
Spearmint Oil, B.P.C..............................................................	Lissapol with Spearmint Oil B.P.C. and Cetrimide B.P.
Strychnine, B.P.C. 1959........................................................	Phenolphthalein with Aloin, Dry Extract of Belladonna, Strychnine B.P.C. 1959 and Ipecacuanha
Sulphacetamide, B.P.C...........................................................	Sulphacetamide B.P.C. with Sulphamerazine B.P. 1958 and Sulphadiazine B.P.
Sulphafurazole, B.P................................................................	—
Sulphamerazine, B.P. 1958...................................................	Sulphamerazine B.P. 1958 with Sulphadiazine B.P. and Sulphathiazole B.P.C.
Sulphamerazine B.P. 1958 with Sulphadiazine B.P. and Sulphacetamide B.P.C.
Sulphamerazine B.P. 1958 with Sulphadiazine B.P. and Sulphadimidine B.P.
Sulphamethoxazole................................................................	—
Sulphaphenazole, B.P.C.........................................................	—
Sulphathiazole, B.P.C.............................................................	Sulphathiazole B.P.C. with Sulphamerazine B.P. 1958 and Sulphadiazine B.P.
Surgical Cement......................................................................	—
Surgical Cement Solvent.......................................................	—
Tacrine......................................................................................	Morphine Sulphate B.P. with Tacrine
Morphine Tartrate with Tacrine
Tetanus Vaccine Purified Toxoid (Aluminium .................................................................................................... Phosphate Adsorbed) B.P......................................................	Diphtheria and Tetanus Vaccine Purified Toxoid (Aluminium Phosphate Adsorbed) B.P.
Diphtheria, Tetanus and Pertussis Vaccine Purified Toxoid (Aluminium Phosphate Adsorbed) B.P.
Tetracycline..............................................................................	Tetracyline with a buffering agent
Tetracycline with a buffering agent and Amphotericin B.
Tetracycline with a buffering agent and Nystatin B.P.
Thioridazine.............................................................................	—
Tragacanth, Indian (Gum Karaya).......................................	—
Trifluoperazine Hydrochloride, B.P.....................................	—
Trimeprazine Tartrate, B.P.C................................................	—
Triprolidine Hydrochloride, B.P...........................................	—
Vasopressin..............................................................................	—
Velactin.....................................................................................	—
Viprynium Embonate, B.P....................................................	—
Vitamin A.................................................................................	Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D
Vitamin D.................................................................................	Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D

 

THIRD SCHEDULE

Regulation 11.

Drugs and Medicinal Preparations Additional to the Drugs and Medicinal Preparations in the British Pharmacopoeia

Acetazolamide Sodium.	Calcium Di-Oxytetracycline.
Acetohexamide.	Calcium Gluconogalactogluconate.
Acetylcysteine.	Calcium Phosphate, B.P.C.
Acidified Golden Syrup, A.P.F. 1955.	Calumba, Concentrated Infusion, B.P. 1948
Acriflavine, B.P.C.	Calumba Tincture, B.P. 1948
Acrylic Resin.	Capsicum Ointment, B.P.C.
Adrenaline Hydrochloride.	Capsicum Tincture, B.P.C.
Adrenaline Mucate.	Carbamazepine.
Agar, B.P.C. 1954.	Carbenoxolone Sodium.
Aldosterone.	Carbinoxamine Maleate.
Alkavervir.	Cardamom Aromatic Tincture, B.P.C.
Allopurinol.	Catechu Tincture, B.P.C.
Aloin, B.P.C.	Cephaloridine.
Almond Oil Volatile Bitter, B.P.C. 1959.	Cetomacrogol Emulsifying Wax, B.P.C.
Aloxidone.	Chloramine, B.P.C.
Aluminium Acetate Solution, B.P.C.	Chloramphenicol Palmitate, B.P.C.
Aluminium Hydroxide Mixture, A.P.F.	Chloramphenicol Stearate.
Aluminium Sodium Polyhydroxy Monocarbonate Hexitol Complex.	Chloramphenicol Succinate.
Aluminium Sodium Silicate.	Chlorazanil Hydrochloride.
Aluminium Powder, B.P.C.	Chlorhexidine Diacetate.
Amaranth Solution, A.P.F.	Chlorhexidine Gluconate.
Amaranth Solution, Compound, A.P.F.	Chlorobenzol Disulphonamide.
Amaranth Solution, B.P.C.	Chlorotrianisene, B.P.C.
Amino Acids.	Chlorthalidone, B.P.C.
Aminocaproic Acid.	Cholera El Tor Combined Vaccine.
Ammonia Aromatic Spirit, B.P.C.	Cinnamon Spirit, B.P.C. 1949.
Ammonia Solution Strong, B.P.C.	Cinnamon Water, Concentrated, B.P.C.
Ammonium Bicarbonate. B.P.C.	Clemizole Hydrochloride.
Ammonium Bromide, B.P.C.	Clemizole Tannate.
Amphotericin B.	Clopamide.
Angiotensin Amide.	Clove, Concentrated Infusion, B.P.C. 1954
Antazoline Methanesulphonate, B.P.C.	Coal Tar, B.P.C.
Antazoline Sulphate.	Cochineal Tincture, B.P. 1948
Attapulgite.	Coconut Oil, B.P.C. 1949
Azathioprine.	Codeine, B.P.C. 1954
Beclamide.	Copper Sulphate, B.P.C.
Beeswax, Yellow, B.P.C.	Creosote, B.P.C. 1959
Belladonna Suppository, B.P. 1948.	Cudbear Tincture, A.P.F. 1947
Benedict’s Solution, A.P.F.	Curd Soap, B.P.C.
Benzalkonium Chloride.	Cyclopenthiazide.
Benzoin, B.P.C.	Cyclothiazide.
Benzoin Compound Tincture, B.P.C.	Cycrimine Hydrochloride.
Benzoin Tincture, B.P.C.	Cymogran.
Benzoinated Lard, B.P.C. 1954	Death Adder Antivenene.
Benzylpenicillin in Oil.	Demecarium Bromide
Bephenium Hydroxynaphthoate, B.P.C.	Deoxycortone Glucoside.
Betamethasone Phosphate.	Desferrioxamine.
Bethanidine Sulphate.	Deslanoside.
Biperiden Hydrochloride.	Dexamethasone Sodium Phosphate.
Bismuth Subgallate, B.P.C.	Dexchlorpheniramine Maleate.
Bretylium Tosylate.	Dextran.
Brompheniramine Maleate.	Dextriferron.
Brown Snake Antivenene.	Diazepam.
Buchu Concentrated Infusion, B.P.C. 1954	Digitalis Tincture, B.P.C. 1959
Butabarbital Sodium.	Dihydroergotamine Methanesulphonate.
Butyl Aminobenzoate, B.P. 1953	Dihydromorphinone Hydrochloride, B.P.C. 1949
Cade Oil, B.P.C.	Dihydrostreptomycin Sulphate, B.P. 1958.
Caffeine and Sodium Benzoate, B.P.C. 1954	Dihydrotachysterol.
Caffeine Citrate, B.P.C. 1959.	Dimethicone, B.P.C.
Cajuput Spirit, B.P. 1948	Dimethindene Maleate.
Calamine Cream Oily, A.P.F.	Diphenylpyraline Hydrochloride.
Calcium Aurothiomalate.

Third Schedule—continued

Dipyridamole.	Isopropramide Iodide.
Disodium Stilboestrol Diphosphate.	Isothipendyl Hydrochloride, B.P.C.
Dithiazanine Iodide	Kanamycin Sulphate, D.P.C.
Dyflos, B.P.C.	Kitasamycin.
Ecothiopate Iodide.	Lanatoside-C.
Entsufon.	Lanette Wax SX.
Ephedrine, B.P.C.	Lavender Spike Oil, B.P.C.
Ergot, Liquid Extract, B.P. 1914.	Lemon Tincture, B.P. 1958.
Erythrityl Tetranitrate.	Lincomycin Hydrochloride.
Erythromycin Ethyl Succinate.	Lipopancreatin.
Erythromycin Glucoheptonate.	Lissapol.
Erythromycin Lactobionate.	Lobelia Ethereal Tincture, B.P.C.
Ethacrynic Acid.	Lofenalac.
Ethanolamine, B.P.C.	Lypressin.
Ethanolamine Oleate.	Magenta, B.P.C.
Ether Nitrous Spirit, B.P.C. 1959	Magnesium-Aluminium Hydroxide.
Ethionamide.	Magnesium Chloride.
Ethoxzolamide.	Magnesium Hydroxide, B.P.C.
Ethylidene Dicoumarin.	Mebhydrolin Napadisylate, B.P.C.
Ethylnoradrenaline Hydrochloride.	Medroxyprogesterone Acetate.
Ethyloestrenol.	Melphalan.
Eucalyptol, B.P.C.	Mepenzolate Bromide.
Ferric Hydroxide.	Mercaptomerin Sodium.
Ferrous Aminoacetosulphate.	Mercuric Chloride, B.P.C.
Ferrous Carbonate Saccharated, B.P.C. 1959	Mestanolone.
Ferrous Phosphate Compound Syrup, B.P.C.	Metaraminol Bitartrate.
Ferrous Phosphate with Quinine and Strychnine Syrup, B.P.C.	Metformin Hydrochloride.
Ferrous Succinate.	Methacycline.
Fluorouracil Sodium.	Methaqualone Hydrochloride.
Folinic Acid.	Methazolamide.
Framycetin Sulphate.	Methdilazine Hydrochloride.
Frusemide.	Methenamine Mandelate.
Fusidic Acid, Diethanolamine Salt.	Methenolone Acetate.
Galactomin, Formula No. 11.	Methotrexate.
Gall and Opium Ointment, B.P.C.	Methoxamine Hydrochloride, B.P.C.
Gelsemium Tincture, B.P.C.	Methsuximide.
Glucagon Hydrochloride.	Methyclothiazide.
Glucose Indicator.	Methyl Glucamine.
Glycerophosphate Compound Syrup, A.P.F.	Methylphenobarbitone, B.P.C.
Glyceryl Guaiacolate.	Methylprednisolone Acetate.
Glycopyrronium Bromide.	Metyrapone.
Glymidine.	Minafen.
Goats Milk, dehydrated.	Morphine Tartrate.
Gramicidin.	Myrrh Gum, Powdered, B.P.C.
Hamamelis Liquid Extract, B.P.C.	Myrrh Tincture, B.P.C.
Hexocyelium Methylsulphate.	Nalidixic Acid.
Honey, Purified, B.P.C.	Nandrolone Decanoate.
Hydrargaphen.	Natamycin.
Hydrocyanic Acid, Dilute, B.P.C. 1954	Niclosamide.
Hydroxybenzoate Compound Powder, A.P.F.	Nicotinyl Alcohol Tartrate.
Hydroxyprogesterone.	Nicoumalone.
Hyoscine Methobromide.	Nitromin.
Hypophosphorous Acid, Dilute, B.P.C.	Nux Vomica, Dry Extract, B.P.C.
Idoxuridine.	Nutramigen.
Indomethacin.	Octatropine Methylbromide.
Insulin Injection, specially purified.	Oestradiol Diproprionate, B.P.C. 1954.
Insulin Injection, Biphasic.	Oestrone, B.P.C. 1954.
Insulin Injection, Neutral.	Oily Ophthalmic Vehicle, A.P.F. 1955.
Insulin Isophane Injection, specially purified.	Orange Peel Compound, Concentrated Infusion, B.P.C. 1954.
Insulin Injection, Special P (Pig).	Orange Peel, Concentrated Infusion, B.P.C.
Iodochlorhydroxyquinoline.	Orciprenaline Sulphate.
Iodoform, B.P.C. 1954	Orphenadrine Hydrochloride.
Iron Aminoates.	Oxycodone Pectinate.
Iron Oxide Saccharated.	Oxymel, B.P.C.
Iron Polymaltose Complex.	Oxymel of Squill, B.P.C.
Iron Sorbitol Complex.	Oxymesterone.
Isoprenaline Hydrochloride.	Oxyphenonium Bromide.

Third Schedule—continued

Oxytetracycline.	Sodium Folate.
Oxytocin.	Sodium Lactate.
Pancreatin Enzyme, U.S.N.F. XI.	Sodium Nitrite, B.P.C.
Papaveretum, B.P.C.	Sodium Potassium Tartrate, B.P.C.
Papuan Black Snake Antivenene.	Sodium Tauroglycocholate, B.P.C. 1954.
Para-Aminosalicylic Acid.	Sodium Thiosulphate.
Paraben Ophthalmic Phosphate Buffer, A.P.F. 1955.	Spearmint Oil. B.P.C.
Paraben Ophthalmic Vehicle, A.P.F. 1955.	Spiramycin.
Paraffin Liquid Light, B.P.C.	Squill Tincture, B.P.C.
Paramethasone Acetate.	Stanolone.
Pargyline Hydrochloride.	Stanozolol.
Pectin.	Stearic Acid, B.P.C.
d-Penicillamine Hydrochloride, B.P.C.	Storax, Prepared, B.P.C.
Penicillinase.	Strophantus Tincture, B.P. 1948.
Penicillin, Benethamine, B.P.C.	Strychnine, B.P.C. 1959.
Pentaerythritol Tetranitrate, diluted, B.P.C.	Sulphacetamide, B.P.C.
Penthienate Methobromide.	Sulphadiazine Sodium, B.P.C.
Peru Balsam, B.P.C.	Sulphaguanidine, B.P.C.
Phenazone, B.P.C.	Sulphamerazine, B.P. 1958.
Phenazopyridine Hydrochloride.	Sulphamethoxazole.
Phenformin Hydrochloride.	Sulphaphenazole, B.P.C.
Pheniramine Maleate.	Sulphasalazine.
Pheniramine Para-Aminosalicylate.	Sulphathiazole, B.P.C.
Phenol Ointment, B.P. 1948	Sulphomyxin Sodium.
Phenoxymethylpenicillin, Benzathine.	Sulphurated Potash, B.P.C.
Phenoxymethylpenicillin, Hydrabamine.	Sulphuric Acid, Dilute, B.P.C.
Phensuximide.	Sulphur Sublimed, B.P.C.
Phenthimentonium.	Sultiame.
Phenytoin.	Surgical Cement.
Phthalylsulphacetamide.	Surgical Cement Solvent.
Physostigmine, B.P.C.	Sustanon.
Pilocarpine Hydrochloride.	Syrup Glucose Liquid, B.P.C.
Pipenzolate Methobromide.	Tacrine.
Pituitary Hormone, Follicle-stimulating.	Taipan Antivenene.
Pituitary Hormone, Growth.	Tar Ointment. B.P.C. 1959.
Pituitary (Posterior Lobe) Powdered, B.P.C.	Tartrazine, B.P.C. 1954.
Polyoestradiol Phosphate.	Testosterone Oenanthate.
Polythiazide.	Tetanus Immune Globulin (Human).
Potable Water.	Tetracosactide.
Potassium Chlorate, B.P.C.	Tetracycline.
Potassium, Effervescent Tablets.	Theophylline Ethanoate of Piperazine.
Prednisolone Sodium Hemisuccinate.	Thiethylperazine.
Prednisolone Sodium Hemisulphate.	Thioridazine.
Prednisolone Tertiary Butyl Acetate.	Thiotepa.
Procarbazine Hydrochloride.	Thyrotrophin.
Propranolol Hydrochloride.	Tiger Snake Antivenene.
Protoveratrine A.	Titanium Dioxide, B.P.C.
Pumilio Pine Oil, B.P.C.	Tolu Tincture, B.P.C. 1959.
Pyrazinamide.	Tragacanth, Indian (Gum Karaya).
Pyridine Aldoxime Methiodide.	Trasylol.
Quillaia Tincture, B.P.C.	Tretamine.
Quinethazone.	Triamcinolone, B.P.C.
Quinidine Bisulphate.	Triamterene.
Raspberry Syrup, B.P.C.	Tridihexethyl Chloride.
Rauwolfia Alkaloids.	Triethanolamine, B.P.C.

Red Back Spider Antivenene.	Trimeprazine Tartrate, B.P.C.
Rolitetracycline.	Trinitrophenol, B.P.C. 1959.
Rosemary Oil, B.P.C.	Trolnitrate Phosphate.
Salicylamide.	Vadrine.
Senega, Concentrated Infusion, B.P.C.	Valerian Ammoniated Tincture, B.P.C.
Senna Compound Mixture, B.P.C. 1959	Vanillin.
Senna, Concentrated Infusion, B.P.C. 1959.	Vasopressin Tannate.
Senna Fruit Extract (Standardised).	Velactin.
Siberian Fir Oil. B.P.C. 1949	Vinblastine Sulphate.
Silver Protein, B.P.C.	Vincristine Sulphate.
Silver Protein Mild, B.P.C.	Vinegar of Squill, B.P.C.
Sobee.	Vitamin A.
Sodium Carbonate Anhydrous, B.P.C.	Vitamin D.
Sodium Edetate, B.P.C.

FOURTH SCHEDULE

Regulation 12.

Additives

Acetone, B.P.C.	Ether Anaesthetic, B.P.
Alcohol (95%), B.P.	Maize Oil, B.P.
Dilute Alcohols, B.P.	Pilocarpine Hydrochloride
Amethocaine Hydrochloride, B.P.	Sodium Thiosulphate B.P.C.
Caraway Oil, B.P.C.	Solution of Burnt Sugar, B.P.C. 1959.
Carmine Solution, A.P.F.	Xylene, B.P.C. 1949.
Citronella Oil, B.P.C.

FIFTH SCHEDULE

Regulation 14.

Pharmaceutical Benefits the Prescribing of Which is Subject to Conditions and Restrictions

Pharmaceutical Benefits............................................................................	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
Acetylcysteine......................................................................	Fibrocystic Disease
Acetylsalicylic Acid Tablets, B.P.......................................................................	Any disease or condition in a pensioner
Soluble Acetylsalicylic Acid Tablets B.P.......................................................................
Acetylsalicylic Acid with Paracetamol and Caffeine Tablets......................................................................
Acrylic Resin......................................................................	Ileostomy or colostomy conditions
Aldosterone......................................................................	With the written authority of the Director-General, treatment of an acute crisis in—
Addison’s disease
Salt-losing congenital adrenal hypoplasia
Allopurinol......................................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Aminocaproic Acid......................................................................
Amino Acids......................................................................
Amitriptyline Tablets, B.P.......................................................................	Any disease or condition in a pensioner
Any disease or condition in a patient receiving treatment in or at an approved hospital
With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital
The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Chlorpromazine Hydrochloride, Trifluoperazine Hydrochloride, Thioridazine Hydrochloride, Amitriptyline Hydrochloride, Imipramine Hydrochloride or Nortriptyline Hydrochloride
Amphetamine Sulphate Tablets, B.P.......................................................................	.	Any disease or condition in a pensioner
Amphotericin B......................................................................		Systemic fungal infection
Ampicillin Capsules, B.P.......................................................................		With the written authority of the Director- General—
Ampicillin Injections, Tablets and Suspension		Gram-negative infections in pregnant women
		Infections, in children under the age of five years, in which penicillin and sulphonamides are not effective
Aneurine Hydrochloride Tablets, B.P	Any disease or condition in a pensioner
Angiotensin Amide......................................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital

   

Fifth Schedule—continued

Pharmaceutical Benefits	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
Ascorbic Acid Tablets, B.P.......................................................	Any disease or condition in a pensioner
Azathioprine.................................................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Beclamide.....................................................................................
Betamethasone Tablets..............................................................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Prednisolone Tablets
Betamethasone Sodium Phosphate Injection, B.P.................	Intra-articular use
Busulphan Tablets, B.P..............................................................	Leukaemia
Any disease or condition in a pensioner
Calciferol Tablets, B.P...............................................................	With the written authority of the Director-General—
Calciferol, B.P..............................................................................	Hypoparathyroidism
Chronic hypoparathyroid tetany
Vitamin D-resistant rickets
Calcium Aminosalicylate..........................................................	Tuberculosis
Calcium Gluconogalactogluconate Effervescent Tablets....	Hypoparathyroidism
Carbamazepine...........................................................................	Epilepsy
........................................................................................................	Trigeminal neuralgia
Carbenoxolone Sodium.............................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Cephaloridine...............................................................................
Chlorambucil Tablets, B.P.........................................................	Malignant lymphoma and related conditions
Chloramine Deodorant Tablets and Powder...........................	Ileostomy or colostomy conditions
Chloramphenicol Capsules, B.P...............................................	Bacterial meningitis
Haemophilus influenzae infections
Intra-ocular infections
Rickettsial infections
Salmonella septicaemia
Typhoid and paratyphoid
Other serious infections sensitive only to Chloramphenicol
Chloramphenicol Injections......................................................	A disease or condition specified in this column in relation to Chloramphenicol Capsules
Chloramphenicol Tablets...........................................................
Chloramphenicol Oral Suspension...........................................
Chlorotrianisene Tablets............................................................	Carcinoma of the prostate
Chloropromazine Hydrochloride..............................................	Any disease or condition in a pensioner
Any disease or condition in a patient receiving treatment in or at an approved hospital
With the written authority of the Director-General—
Late-stage malignancy
Radiation sickness
Huntington’s chorea
With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital
The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Chlorpromazine Hydrochloride, Trifluoperazine Hydrochloride, Thioridazine Hydrochloride, Amitriptyline Hydrochloride, Imipramine Hydrochloride, or Nortriptyline Hydrochloride
Chlortetracycline Capsules, B.P...............................................	Brucellosis
Herpes zoster ophthalmicus
Intestinal amoebiasis
Leptospirosis
Lymphogranuloma venereum

   

Fifth Schedule—continued

Pharmaceutical Benefits	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
Chlortetracycline Capsules B.P.—continued	Psittacosis
	Rickettsial infections
Any bacterial infections or actinomycosis or trachoma where these cannot be treated safely and effectively by sulphonamides or penicillins
Pre-operative and post-operative therapy where there are reasonable grounds for believing that infection may occur
Chlortetracycline Hydrochloride Granules	A disease or condition specified in this column in relation to Chlortetracycline Capsules
Cloxacillin Sodium, B.P.............................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Cloxacillin Capsules. B.P..........................................................
Codeine Phosphate with Acetylsalicylic Acid Soluble Tablets	Any disease or condition in a pensioner
Codeine Phosphate with Acetylsalicylic Acid Tablets
Codeine Phosphate with Acetylsalicylic Acid and Paracetamol soluble Tablets
Codeine Phosphate with Acetylsalicylic Acid, Paracetamol and Caffeine Tablets
Cod Liver Oil Emulsion.............................................................	Any disease or condition in a child under the age of twelve years or in a pensioner
Colistin Sulphomethate Injection, B.P.	Pyocyaneus infection and Gram-negative infections where no other drug is effective
Corticotrophin Injection, B.P.	With the written authority of the Director-General—
Corticotrophin Gelatin Injection, B.P.	A disease or condition specified in this column in relation to Cortisone Injection
Corticotrophin Zinc Hydroxide Injection, B.P.
	Hypsarrhythmia
	Salaam convulsions
	The prevention of side effects of corticosteroid therapy
Cortisone Injection, B.P.............................................................	With the written authority of the Director-General—
Acute exophthalmic ophthalmoplegia
Acute heart block complicating myocardial infarction
Anaemia, acquired haemolytic
Addison’s disease
Adrenocortical hypoplasia
Adrenalectomy, total
Adrenogenital syndrome
Agranulocytosis
Behcet’s syndrome
Cerebral tumours and cerebral oedema
Cranial arteritis
Cushing’s syndrome, including hyperadrenocorticalism
Dermatitis, acute exfoliative
Dermatomyositis
Encephalomyelitis
Encephalomyelitis, acute disseminated
Guillain-Barré syndrome
Hamman-Rich syndrome—diffuse interstitial pulmonary fibrosis
Hansen’s disease
Hepatitis, progressive or continuing, proven by biopsy Or biochemistry
Hodgkin’s disease
Idiopathic hypercalcaemia
Inflammatory conditions of the uveal tract and retina
Interstitial Keratitis due to syphilis or vernal conjunctivitis
Keratoplasty
Leucine-sensitive hypoglycaemia

Fifth Schedule—continued

Pharmaceutical Benefits

Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act

Cortisone Injection, B.P.—continued

Leukaemia

Lymphosarcoma and follicular lymphoma

Metastatic breast cancer

Mycosis fungoides

Nephrosis or nephrotic syndrome

Neuromyelitis optica

Opticneuritis following removal of tumor of the brain

Panhypopituitarism

Pemphigus

Periarteritis nodosa

Progressive transverse myelitis

Pseudohermaphroditism

Purpura, Henoch’s

Purpura, thrombocytopenic

Regional ileitis (Crohn’s disease)

Recticulum cell sarcoma

Rheumatic carditis, acute

Sarcoidosis

Scleroderma

Severe reactions of the skin and mucosa following X-ray therapy

Splenic neutropenia

Status asthmaticus

Steroid therapy prior to operation in patients under steroid therapy

Stevens-Johnson syndrome

Still’s disease in a child under the age of sixteen years

Sympathetic ophthalmitis

Systemic lupus erythematosus

Temporal arteritis

Treatment of malignancy in conjunction with radiotherapy or chemotherapy

Tropical and non-tropical sprue and all forms of malabsorption associated with those diseases

Type II Nephritis

Ulcerative colitis proven by sigmoidscopy or radiological report

Cortisone Tablets, B.P................................................................

With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection

Established megalocytic anaemia

Cyanocobalamin Injection, B.P................................................

Neuroblastoma

Subacute combined degeneration of the cord

Cymogran.....................................................................................

With the written authority of the Director-General, phenylketonuria

Cycloserine Tablets, B.P............................................................

Any disease or condition in a patient receiving treatment in or at an approved hospital

Cycloserine Capsules, B.P.........................................................

Demethylchlortetracycline Capsules, B.P

A disease or condition specified in this column in relation to Chlortetracycline Capsules, except herpes zoster ophthalmicus

Demethylchlortetracycline Hydrochloride Oral Paediatric Drops and Oral Suspension

Demethylchlortetracycline Hydrochloride with Nystatin

Any disease or condition specified in this column in relation to Oxytetracycline Hydrochloride with a buffering agent and Nystatin

Deodorant Detergent Solution (Lissapol with Spearmint Oil and Cetrimide)

Ileostomy or colostomy conditions

Deoxycortone Aqueous Injections

Addison’s disease

Adrenalectomy, total

Deoxycortone Acetate Injection, B.P.

Deoxycortone Trimethylacetate Injection, B.P.

Deoxycortone Acetate Implants, B.P.

Deoxycortone Acetate Tablets..................................................

 

Fifth Schedule—continued

Pharmaceutical Benefits	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
Desferrioxamine..........................................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Dexamethasone Tablets, B.P....................................................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Prednisolone Tablets
Dexamethasone Sodium Phosphate Injections	Intra-articular use
Dexamphetamine Tablets, B.P..................................................	Any disease or condition in a pensioner
Diazepam Injection, Syrup and 10 mg. tablet	Any disease or condition in a patient receiving treatment in or at an approved hospital
Diazepam Tablets 2 mg. and 5 mg.	Treatment in multiple sclerosis
Dienoestrol Cream......................................................................	Any disease or condition in a pensioner
Dienoestrol Tablets, B.P............................................................	Carcinoma of the prostate
Mammary carcinoma
Any disease or condition in a pensioner
Dihydrostreptomycin Sulphate Injection	As an alternative to Streptomycin Sulphate in the case of a person who is being treated for a disease or condition specified in this column in relation to Streptomycin Sulphate and who is allergic to Streptomycin Sulphate
Dihydrotachysterol......................................................................	Parathyroid deficiency
Diloxanide Furoate Tablets, B.P..............................................	Amoebic dysentery
Dimethicone.................................................................................	Ileostomy or colostomy conditions
Disodium Stilboestrol Diphosphate.........................................	Carcinoma of the prostate
Dithiazanine Iodide	Infestations of Trichuris trichiura or Strongyloides stercoralis
Ditophal........................................................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Erythromycin...............................................................................	Brucellosis
Intestinal amoebiasis
Leptospirosis
Lymphogranuloma venereum
Mycoplasma pneumoniae (Eaton’s Agent)
Psittacosis
Rickettsial infections
Staphylococcal septicaemia or staphylococcal pneumonia
Any bacterial infections or spirochaetal infection or actinomycosis or trachoma where these cannot be treated safely and effectively by sulphonamides or penicillins
Pre-operative and post-operative therapy where there are reasonable grounds for believing that infection may occur
Ethinyloestradiol Tablets, B.P..................................................	Any disease or Condition in a pensioner
Hereditary telangiectasis
Pre-menopausal castration syndrome
Turner’s syndrome
Ethionamide.................................................................................	Tuberculosis
Ethisterone Tablets, B.P.............................................................	Turner’s syndrome
Ethyloestrenol..............................................................................	With the written authority of the Director-General, intermittent use for corticosteroid-induced osteoporosis
Fludrocortisone Tablets, B.P.....................................................	Addison’s disease
Adrenocortical hypoplasia
Total adrenalectomy
Fluorouracil Sodium...................................................................	Carcinoma of the colon and rectum
Fluoxymesterone Tablets, B.P..................................................	Castration syndrome (male)
Mammary carcinoma
With the written authority of the Director-General, intermittent use for corticosteroid-induced osteoporosis
Folic Acid Injection....................................................................	Macrocytic anaemia
Folic Acid Tablets, B.P..............................................................	Sprue or the spruc-like syndrome
Folinic Acid..................................................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Framycetin Sulphate Tablets.....................................................

Bowel sterilization preparatory to major surgery
Fusidic Acid (Sodium Salt or Diethanolamine Salt)	With the written authority of the Director-General, infections where positive bacteriological evidence confirms that Fusidic Acid (Sodium Salt or Diethanolamine Salt) is the only appropriate antibiotic

 

Fifth Schedule—continued

Pharmaceutical Benefits	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
Galactomin Formula No. 11......................................................	With the written authority of the Director-General—
Galactosaemia
Conditions needing an extreme restriction of lactose in the patient’s diet, in children under the age of four years
Goats Milk, dehydrated.............................................................	With the written authority of the Director-General, cows milk allergy in children under the age of four years
Griseofulvin Tablets, B.P...........................................................	With the written authority of the Director-General, for use in severe tinea infections due to Microsporum, Trichophyton or Epidermophyton species which have been proven by laboratory examination
Halibut Liver Oil Capsules........................................................	Any disease or condition in a pensioner
Hexachlorophane with Entsufon..............................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Hexachlorophane with Lissapol...............................................
Hexachlorophane in Soap Solution..........................................
Hydrocortisone Injection...........................................................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection
Hydrocortisone Acetate Injection, B.P.	Intra-articular use
Hydrocortisone Sodium Succinate Injection	Acute adrenal failure due to medical or surgical crises
	Prophylaxis of adrenal insufficiency during and after major surgery for patients already on steroid therapy
Stevens-Johnson syndrome
Established megalocytic anaemia
Hydroxocobalamin Injection, B.P.	Neuroblastoma
Sub-acute combined degeneration of the cord
Endometrial carcinoma
Hydroxyprogesterone.................................................................	Habitual abortion
Progesterone deficiency proven by hormonal assay of lateral wall smear
Idoxuridine...................................................................................	Infections caused by Herpes Simplex Virus
Imipramine Tablets, B.P............................................................	Any disease or condition in a pensioner
Any disease or condition in a patient receiving treatment in or at an approved hospital
With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital
The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Chlorpromazine Hydrochloride, Trifluoperazine Hydrochloride, Thioridazine Hydrochloride, Amitriptyline Hydrochloride, Imipramine Hydrochloride or Nortriptyline Hydrochloride
Indomethacin Capsule....................................................................	Rheumatoid arthritis or osteroarthritis not responding to salicylates
Acute attacks of gout
Isoniazid Tablets, B.P.....................................................................	Tuberculosis
Kanamycin Sulphate Capsules, Injections and Oral Solution	With the written authority of the Director-General, infections where positive bacteriological evidence confirms that Kanamycin Sulphate is the only appropriate antibiotic
Kitasamycin.....................................................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Levorphanol Tartrate.......................................................................	Obstetrical use
Severe intractable pain
Lincomycin Hydrochloride.............................................................	Osteomyelitis
Pneumococcal Meningitis
Liothyronine Tablets, B.P..............................................................	Myxoedema
Myxoedema coma

 

Fifth Schedule—continued

Pharmaceutical Benefits	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
Lipopancreatin............................................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Lofenalac.....................................................................................	With the written authority of the Director-General, phenylketonuria
Medroxyprogesterone Acetate Tablets	Endometrial carcinoma
Medroxyprogesterone Acetate Injections	Endometrial carcinoma
	Progesterone deficiency proven by hormonal assay of lateral wall smear
Melphalan....................................................................................						Malignant melanoma
Multiple myeloma
Mercaptopurine Tablets, B.P.....................................................	Allergic angiitis
Leukaemia
Lupus erythematosus
Periarteritis
Mestanolone................................................................................	Mammary carcinoma
With the written authority of the Director-General, intermittent use for corticosteroid-induced osteoporosis
Methacycline...............................................................................	A disease or condition specified in this column in relation to Chlortetracycline Capsules, except herpes zoster ophthalmicus
Methandienone Tablets, B.P.....................................................	With the written authority of the Director-General, intermittent use for corticosteroid-induced osteoporosis
Methenolone Acetate.................................................................
Methicillin Sodium.....................................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Methicillin Injection, B.P...........................................................
Methotrexate Tablets.................................................................	Leukaemia and neoplastic disease
Methotrexate Injections.............................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Methylamphetamine Injection, B.P.........................................	Any disease or condition in a pensioner
Methylamphetamine Tablets, B.P............................................
Metyrapone..................................................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Minafen........................................................................................	With the written authority of the Director-General, phenyl ketonuria
Morphine Sulphate, B.P. with Tacrine Tablets	Severe intractable pain
	Mustine Hydrochloride Injection.............................................	Malignant lymphoma and related conditions
Nalidixic Acid..............................................................................	With the written authority of the Director-General, urinary tract infections
Nandrolone Phenylpropionate Injection, B.P.........................	With the written authority of the Director-General, intermittent use for corticosteroid-induced osteoporosis
Nandrolone Decanoate..............................................................	Mammary carcinoma
With the written authority of the Director-General, intermittent use for corticosteroid-induced osteoporosis
Neomycin Tablets, B.P...............................................................	Bowel sterilization preparatory to major surgery
Portal-systematic encephalopathy
Nicotinic Acid Tablets, B.P.......................................................	Any disease or condition in a pensioner
Nitrofurantoin Tablets, B.P.......................................................	Urinary tract infections
Nitrofurantoin Oral Suspension................................................
Nitromin........................................................................................	Malignant lymphoma and related conditions
Any disease or condition in a pensioner
Any disease or condition in a patient receiving treatment in or at an approved hospital
				With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital
Nortriptyline Hydrochloride, B.P.
Nortriptyline Tablets, B.P..........................................................
Nortriptyline Capsules, B.P.......................................................
The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further

 

Fifth Schedule—continued

Pharmaceutical Benefits	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
Nortriptyline Hydrochloride, B.P.	treatment with Chlorpromazine Hydrochloride, Trifluoperazine Hydrochloride, Thiordazine Hydrochloride, Amitriptyline Hydrochloride, Imipramine Hydrochloride or Nortriptyline Hydrochloride
Nortriptyline Tablets, B.P..........................................................
Nortriptyline Capsules, B.P.—continued
Nutramigen...................................................................................	With the written authority of the Director-General—
Cows milk allergy in children under the age of four years
Galactosaemia
Lactose intolerance
Fibrocystic disease of the pancreas in children under the age of four years
Nystatin Tablets, B.P..................................................................	Monilia infections
Orciprenaline Sulphate Injection.............................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Orciprenaline Sulphate Solution for Inhalation
Oxycodone Pectinate..................................................................	Late-stage malignancy
Oxymesterone..............................................................................	With the written authority of the Director-General, intermittent use for corticosteroid-induced osteoporosis
Oxytetracycline Hydrochloride Capsules
Oxytetracycline Tablets, B.P.....................................................	A disease or condition specified in this column in relation to Chlortetracycline Capsules except herpes zoster ophthalmicus
Oxytetracycline Injections........................................................
Calcium di-Oxytetracycline Oral Suspension
Calcium di-Oxytetracycline Paediatric Drops
Oxytetracycline Hydrochloride with a buffering agent and Nystatin	Broad spectrum antibiotic therapy of premature infants, of patients under steroid therapy or of cases complicated by intestinal moniliasis
	A second or repeated course of broad spectrum antibiotic therapy for a disease or condition specified in this column in relation to Chlortetracycline Capsules except herpes zoster ophthalmicus
Pancreatin, B.P.............................................................................	Fibrocystic disease
	Pancreatico-duodenectomy
Pancreatin Enzyme U.S.N.F. XI...............................................	Pancreatic steatorrhoea
Para-Aminosalicylic Acid..........................................................	Tuberculosis
Paracetamol Suspension............................................................	Any disease or condition in a pensioner
Paracetamol Tablets, B.P...........................................................
Paracetamol with Codeine Phosphate and Pentobarbitone Sodium	Any disease or condition in a pensioner
Paramethasone Acetate.............................................................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection
Paraffin Liquid Emulsion...........................................................	Any disease or condition in a pensioner
Paraffin Liquid Emulsion with Phenolphthalein
Pargyline Hydrochloride............................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Penicillamine................................................................................	With the written authority of the Director-General—
Cystinosis
Cystinuria with calculus formation
Treatment of cold agglutinin haemoglobinuria
Acute heavy metal intoxication
Wilson’s Disease (hepatolenticular degeneration)
Penicillin Benzathine Tablets and Capsules	Prevention of recurrent streptococcal infections, including rheumatic fever
Penicillin Benzyl Tablets, B.P..................................................
Penicillin Benzyl Capsules........................................................
Benzylpenicillin injection 5,000,000 units and 10,000,000 units	Bacterial endocarditis or septicaemia
Benzylpenicillin with Streptomycin Sulphate
Benzylpenicillin with Procaine Penicillin and Streptomycin Sulphate	Endocarditis due to Streptococcus faccalis or Streptococcus viridans

 

Fifth Schedule—continued

Pharmaceutical Benefits	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
Pethidine Hydrochloride with Levallorphan Tartrate	Obstetrical use
Phenylbutazone Tablets B.P......................................................	Acute attacks of gout
Phenylbutazone Capsules..........................................................	Osteoarthritis or Rheumatoid Arthritis not responding to salicylates
Phytomenadione Injection, B.P................................................	Antidote to anticoagulants
Pituitary, Posterior Lobe, Insufflation	Diabetes insipidus
Polymyxin B. Sulphate Injection.............................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Polyoestradiol Phosphate..........................................................	Carcinoma of the prostate
Prednisolone Sodium Phosphate Retention Enema and Suppository	With the written authority of the Director-General—
	Ulcerative colitis proven by sigmoidoscopy or radiological report
Proctitis proven by sigmoidoscopy
Prednisolone Tablets, B.P..........................................................	With the written authority of the Director-General—
Cerebral oedema; Cerebral tumors; Acute exophthalmic ophthalmoplegia; Interstitial keratitis due to syphilis or vernal conjunctivitis; Malignancy treatment in conjunction with radiotherapy or chemotherapy; Acute heart block complicating myocardial infarction
Nodular non-suppurative panniculitis (Christian-Weber disease)
A disease or condition specified in this column in relation to Cortisone Injection except total adrenalectomy, Addison’s disease or adrenocortical hypoplasia
Prednisolone Acetate Injection.................................................
Prednisolone Methyl Acetate Injections
Prednisolone Tertiary Butyl Acetate Injections	Intra-articular use
Prednisolone Trimethylacetate Injections
Methylprednisolone Tablets, B.P.	With the written authority of the Director-General, a disease or condition specified in this column in relation to Prednisolone Tablets.
Methylprednisolone Capsules...................................................
Prednisolone Sodium Hemisuccinate	Prophylaxis of adrenal insufficiency during and after major surgery for patients already on steroid therapy
With the written authority of the Director-General, medical or surgical crises
Prednisone Tablets, B.P.............................................................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Prednisolone Tablets
Procarbazine Hydrochloride......................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Habitual abortion
Progesterone.................................................................................	Progesterone deficiency proven by hormonal assay of lateral wall smear
Propranolol Hydrochloride........................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Pyrazinamide...............................................................................
Pyridostigmine Injection, B.P...................................................
Pyridostigmine Tablets, B.P......................................................	Myasthenia gravis
Pyridoxine Hydrochloride Tablets	Peripheral neuritis due to isoniazid therapy
Radiation sickness
Quinine Bisulphate Tablets, B.P...............................................
Quinine Dihydrochloride Tablets.............................................
Quinine Hydrochloride Tablets................................................	Malaria
Quinine Sulphate Tablets, B.P..................................................
Riboflavine Tablets.....................................................................
Senna Fruit Extract (Standardised) Sobee..............................	Any disease or condition in a pensioner
With the written authority of the Director-General—
Galactosaemia
Lactose intolerance
Milk allergy in children under the age of four years

Fifth Schedule—continued

Pharmaceutical Benefits	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
Sodium Aminosalicylate Tablets, B.P.
Sodium Aminosalicylate Injection
Sodium Aminosalicylate Cachets	Tuberculosis
Sodium Aminosalicylate Granules
Sodium Aminosalicylate with Isoniazid B.P.
Sodium Folate..............................................................................

Macrocytic anaemia
Sprue or the sprue-like syndrome
Spiramycin...................................................................................	Serologically proven active toxoplasmosis
Staphylococcal septicaemia or staphylococcal pneumonia
Any gram-positive bacterial infections where these cannot be treated safely and effectively by sulphonamides or penicillins
Spironolactone Tablets, B.P......................................................	With the written authority of the Director-General, to supplement other diuretics when these have proved inadequate
Stanolone......................................................................................	Mammary carcinoma
With the written authority of the Director-General, intermittent use for corticosteroid-induced osteoporosis
Stanozolol.....................................................................................	With the written authority of the Director-General, intermittent use for corticosteroid-induced osteoporosis
Carcinoma of the prostate
Stilboestrol Injection..................................................................	Mammary carcinoma
Stilboestrol Tablets, B.P.............................................................	Any disease or condition in a pensioner
Heriditary Telangiectasis
Streptomycin Sulphate Injections............................................	Bacillary dysentery that is resistant to the Sulphonamides
Brucellosis
Chancroid
Endocarditis due to Streptococcus faecalis or Streptococcus viridans
Friedlander bacillus infections
Haemophilus influenzae infections
Plague
Pseudomonas pyocyanea infections
Rat-bite fever (Streptobacillus moniliformis)
Salmonella infections
Surgical conditions of the bowel (pre-operative and postoperative)
Surgical conditions of the thoracic organs
Tuberculosis
Tularaemia
Urinary tract infections that are resistant to the Sulphonamides
Sulphasalazine.............................................................................	Ulcerative colitis
Sulphomyxin Sodium.................................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Sultiame........................................................................................	For use where other anticonvulsants have failed
Surgical Cement..........................................................................	Ileostomy or colostomy conditions
Surgical Cement Solvent...........................................................
Sustanon.......................................................................................
Testosterone Implants, B.P........................................................
Testosterone Oenanthate...........................................................	Castration syndrome (male)
Testosterone Proprionate Injection, B.P.	Klinfelter Reifenstein Albright syndrome
	Mammary carcinoma
Methyltestosterone Tablets, B.P...............................................
Methyltestosterone, B.P.............................................................
Tetanus Antitoxin, B.P. (Bovine).............................................	Patients known to be sensitive to horse serum
Tetanus Immune Globulin (Human)	With the written authority of the Director-General, where patients are known to be sensitive to horse serum and cattle serum
Tetracosactide.............................................................................					Any disease or condition in a patient receiving treatment in or at an approved hospital

Fifth Schedule—continued

Pharmaceutical Benefits	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
Tetracycline Capsules, B.P........................................................
Tetracycline Tablets, B.P...........................................................
Tetracycline Injections...............................................................	A disease or condition specified in this column in relation to Chlortetracycline Capsules except herpes zoster ophthalmicus
Rolitetracycline............................................................................
Tetracycline Hydrochloride Granules, Paediatric Drops and Syrup
Tetracycline with a buffering agent
Tetracycline with a buffering agent and Amphotericin B	A disease or condition specified in this column in relation to Oxytetracycline Hydrochloride with a buffering agent and Nystatin
Tetracycline with a buffering agent and Nystatin
Thiambutosine Tablets, B.P.......................................................	Hansen’s disease
Thiambutosine Injection............................................................
Thiethylperazine Tablets and Suppositories	With the written authority of the Director-General—
	Radiation sickness
	Any disease or condition in a pensioner
	Any disease or condition in a patient receiving treatment in or at an approved hospital
	With the written authority of the Director-General—
	Late-stage malignancy
	Radiation sickness
	With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital
Thioridazine Tablets, B.P..........................................................
Thioridazine.................................................................................
The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Chlorpromazine Hydrochloride, Trifluoperazine Hydrochloride, Thioridazine Hydrochloride, Amitriptyline Hydrochloride, Imipramine Hydrochloride or Nortriptyline Hydrochloride
Thyrotrophin................................................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Tragacanth, Indian (Gum Karaya)	Ileostomy or colostomy conditions
Trasylol.........................................................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Tretamine.....................................................................................	Malignant lymphoma and related conditions
Triamcinolone.................................................................................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Prednisolone Tablets
	Any disease or condition in a pensioner
	Any disease or condition in a patient receiving treatment in or at an approved hospital
	With the written authority of the Director-General—
	Late-stage malignancy
	Radiation sickness
	With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital
Trifluoperazine Tablets, B.P..........................................................
Trifluoperazine Hydrochloride, B.P.
	The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Chlorpromazine Hydrochloride, Trifluoperazine Hydrochloride, Thioridazine Hydrochloride, Amitriptyline Hydrochloride, Imipramine Hydrochloride or, Nortriptyline Hydrochloride

Fifth Schedule—continued

Pharmaceutical Benefits	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
Trimetaphan Injection, B.P.....................................	Hypotensive for anaesthesia
Vadrine.................................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Vasopressin Nasal Spray........................................	Diabetes insipidus
Velactin.................................................................	With the written authority of the Director-General—
Galactosaemia
Lactose intolerance
Milk allergy in children under the age of four years
Vinblastine Sulphate..............................................	Hodgkin’s disease
Vincristine Sulphate...............................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Viomycin Sulphate.................................................	Tuberculosis
Viomycin Sulphate Injection, B.P.
Vitamin A with Aneurine Hydrochloride, Riboflavine, Nicotinamide, Ascorbic Acid and Vitamin D	Any disease or condition in a pensioner

                  

_____________________

By Authority: A. J. Arthur, Commonwealth Government Printer, Canberra